Following a strengthened shareholder base and the first baby enrolled in Neola Medical’s Swedish clinical pilot study, CEO Hanna Sjöström joins Redeye to discuss recent milestones and what lies ahead.
She shares insights into the company’s clinical progress, recent international patent grants, and the path toward U.S. market readiness, including upcoming plans for the pivotal clinical study and key strategic considerations around manufacturing.
Watch the full interview here: Redeye Interview with CEO Hanna Sjöström following Neola Medical’s Q1 2025 report
Access the interview and additional insights from Redeye here: https://www.redeye.se/company/neola-medical